Newsletter
Every new paper in this field, in your inbox.
Definitive chemoradiotherapy (DCRT) yields poor overall and progression-free survival for patients with adenocarcinoma of the esophagus or esophago-gastric junction, underscoring the need for careful patient selection and treatment strategy refinement.
High pre-treatment serum interleukin-10 levels are associated with significantly worse overall survival in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy.
After neoadjuvant chemoradiotherapy for esophageal cancer, regrowth predominantly affects the mucosal and submucosal layers, suggesting implications for surgical vigilance.
Achieving textbook outcomes (TO) and textbook oncological outcomes (TOO) is linked to significantly better overall survival and disease-free survival after gastric and esophageal cancer surgeries.
Intraoperative adverse events (IAEs) during robot-assisted minimally invasive esophagectomy (RAMIE) can occur in about 8.6% of cases, but most are managed robotically without conversion to open surgery.
A nomogram can help predict early postoperative deep vein thrombosis (DVT) in gastric and colorectal cancer patients despite routine anticoagulant prophylaxis.
This systematic review shows that Heller's myotomy and peroral endoscopic myotomy (POEM) outperform botulinum toxin for long-term symptom relief in primary achalasia.
Neoadjuvant chemoradiation-immunotherapy offers better pathologic complete response rates compared to neoadjuvant chemoimmunotherapy alone in patients with locally advanced esophageal squamous cell carcinoma, but it comes with increased postoperative pulmonary complications without improving long-term survival.
In patients with locally advanced esophageal squamous cell carcinoma, neoadjuvant chemoimmunotherapy (ncit) significantly improves three-year overall survival compared to standard chemoradiotherapy (ncrt).
A new study identifies key predictors of early recurrence in gastric cancer patients after curative gastrectomy, developed specifically for a non-East Asian cohort.
